Novartis India Board of Directors
Get the latest insights into the leadership at Novartis India. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Chandni Maru | Company Secretary & Compliance Officer |
| Christopher Snook | Chairperson |
| Sandra Martyres | Non Executive Independent Director |
| Sanker Parameswaran | Non Executive Independent Director |
| Gira Sardesai | Non Executive Independent Director |
| Shilpa Joshi | Whole Time Director & Chief Financial Officer |
| Falin Majmudar | Whole Time Director |
Novartis India FAQs
The board at Novartis India consists of experienced professionals, including Chandni Maru, Christopher Snook, and others, overseeing the company’s strategic and corporate governance.
Directors at Novartis India are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Chandni Maru is the current chairman at Novartis India.
Executive directors at Novartis India are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Novartis India adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Novartis India, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
